Amit Verma
0000-0002-5408-1673
2 papers found
Refreshing results…
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial
PU.1-Dependent Enhancer Inhibition Separates Tet2-Deficient Hematopoiesis from Malignant Transformation
Missing publications? Search for publications with a matching author name.